SHIFOXONADAN TASHQARI KORONAVIRUSLI PNEVMONIYADAN KEYIN BEMORLARDA MARKAZIY GEMODINAMIKANI VA TASHQI NAFAS OLISHNI BAHOLASH NATIJALARI
##article.subject##:
Shifoxonadan tashqari pnevmoniya, markaziy gemodinamika, tashqi nafas, COVID-19, SARS-CoV-2, hujayra shikastlanishi, hujayra membranasining yorilishi, ishemiya, yallig'lanish sitokinlari, chandiq va perikardit##article.abstract##
Koronavirusli pnevmoniya bilan og'rigan bemorlarning soni ortib borishi bilan birga, ularning soni ortib borayotgani charchoq, yurak urishi, jismoniy faollikning pasayishi, nafas qisilishi, ko'krak qafasidagi og'riqlar, neyrokognitiv qiyinchiliklar, mushaklarning og'rig'i va zaifligi, depressiya, tashvish va boshqa alomatlarni tasvirlashda davom etmoqda. ruhiy salomatlik muammolari. Ushbu alomatlar virusli infektsiyaning o'tkir bosqichi o'tgandan keyin bir necha hafta davom etadi. Greenhalgh va boshqalar, agar alomatlar kasallik boshlanganidan keyin 3-12 hafta davom etsa, bu holatni o'tkir COVID-19, agar alomatlar 3 oydan ortiq davom etsa, uzoq muddatli COVID-19 deb tasnifladi. Ushbu ta'riflar ular o'tkazgan tadqiqotlar natijasida olingan. Ushbu kasallikning tarqalishi to'g'risidagi ma'lumotlar tadqiqotdan tadqiqotga, barcha holatlarning o'ndan ellik foizigacha farq qiladi. Uzoq muddatli COVID-19 sindromi boshqa og'ir infektsiyalardan keyingi o'tkir post-o'tkir sindromlarga nisbatan noyobdir, chunki u hatto engil va o'rtacha darajadagi infektsiyalari bo'lgan va intensiv terapiya bo'limiga yotqizishni talab qilmaydigan bemorlarda ham tasvirlangan. Bu boshqa og'ir infektsiyalardan keyin rivojlanadigan boshqa post-o'tkir sindromlardan farq qiladi. O'tkir COVID-19 dan keyin rivojlanish uchun javobgar bo'lgan jarayonlar haqida to'liq tushunchaga ega emasmiz. Ba'zi mualliflar surunkali dikondisirlangan antikor reaktsiyasi, yallig'lanish va immunologik reaktsiyalar, shikastlanishdan keyingi stress yoki hatto SARS-CoV-2 virusi bilan qaytalanish va / yoki qayta infektsiya sabab bo'lishi mumkin, deb taxmin qilishdi. Bu holatlar miyokardning shikastlanishi va yallig'lanish xavfini oshirishi mumkin, bu esa keyinchalik yurakning chap qorincha disfunktsiyasiga olib kelishi mumkin.
O'tkir COVID-19 ni davolash ko'plab asoratlar bilan bog'liq, chunki aniq tavsiyalar mavjud emas. Bizning ma'lumotimizga ko'ra, hozirgi vaqtda o'tkir COVID-19 bilan og'rigan bemorlarni, xususan, transtorasik ekokardiyografi (TTE) bilan baholangan yurak-qon tomir (YuQT) kasalliklarini har tomonlama baholagan, doimiy o'zgarishlar qay darajada sabab bo'lishi mumkinligini aniqlash uchun oz sonli tadqiqotlar mavjud. simptomlarning davom etishi uchun. Bundan tashqari, o'tkir COVID-19 dan tuzalib ketgan bemorlarning funktsional holatini baholash uchun shkalalarni ishlab chiqishga bir nechta urinishlar qilingan; ammo, bu bemorlarning keyingi parvarishi hali ham munozarali masala.
Библиографические ссылки
Babapoor-Farrokhran, S., Rasekhi, R. T., Gill, D., Babapoor, S., & Amanullah, A. (2020). Arrhythmia in COVID-19. SN Comprehensive Clinical Medicine, 2, 1430-1435.
Назаров Ф. Ю., Ярмухамедова С. Х. Медико-социальные аспекты профилактики среди студенческой молодежи в условиях пандемии COVID-19 //Science and Education. – 2022. – Т. 3. – №. 12. – С. 256-263.
Назаров Ф. Ю., Азизова Ш. К. ТИЧЕНИЕ ВИРУСНОЙ ПНЕВМОНИЕ COVID-19 У БОЛЬНЫХ С ВРОЖДЕННЫМ ПОРОКА СЕРДЦА У МОЛОДЫХ ЛИЦ //Scientific progress. – 2022. – Т. 3. – №. 2. – С. 891-894.
Назаров Ф. Ю., Ярмухамедова С. Х. Клинико–Организационноеобоснование У Больных С Вирусной Пневмонией, Вызванной SARS–CоV–2 //Miasto Przyszłości. – 2022. – Т. 30. – С. 229-232.
Назаров Ф. Ю., Махмудова Х. Д. Нарушений в состоянии здоровья, в том числе в физическом развитии у молодежи в условиях пандемии COVID-19 //Science and Education. – 2022. – Т. 3. – №. 12. – С. 264-272.
Nazarov F. Y., Bekmuradova M. S. RESEARCH OF LOCAL CONTRACTABILITY OF THE MYOCARDIAL WITH THE HELP OF TISSUE DOPPLERA STREETS SUFFERING WITH DILATED CARDIOMYOPATHY //Galaxy International Interdisciplinary Research Journal. – 2022. – Т. 10. – №. 1. – С. 317-319.
Nazarov F. Y., Yarmatov S. T. Optimization of methods for prevention and intensive therapy of complications in pregnant women with chronic syndrome of Disseminated Intravascular Coagulation //Journal of Advanced Medical and Dental Sciences Research. – 2020. – Т. 8. – №. 9. – С. 82-85.
Benkalfate, N., Eschapasse, E., Georges, T., Leblanc, C., Dirou, S., Melscoet, L., ... & Lemarchand, P. (2022). Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia. BMJ open respiratory research, 9(1), e001136.
Dixit, N. M., Churchill, A., Nsair, A., & Hsu, J. J. (2021). Post-acute COVID-19 syndrome and the cardiovascular system: what is known?. American heart journal plus: cardiology research and practice, 5, 100025.
Greenhalgh, T., Knight, M., Buxton, M., & Husain, L. (2020). Management of post-acute covid-19 in primary care. bmj, 370.
Herrera, J. E., Niehaus, W. N., Whiteson, J., Azola, A., Baratta, J. M., Fleming, T. K., ... & Abramoff, B. (2021). Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS‐CoV‐2 infection (PASC) patients. Pm & R, 13(9), 1027.
Hussein, A. A. M., Saad, M., Zayan, H. E., Abdelsayed, M., Moustafa, M., Ezzat, A. R., ... & Sayed, I. (2021). Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities. Annals of Thoracic Medicine, 16(3), 260.
Maltezou, H. C., Pavli, A., & Tsakris, A. (2021). Post-COVID syndrome: an insight on its pathogenesis. Vaccines, 9(5), 497.
Moreno-Pérez, O., Merino, E., Leon-Ramirez, J. M., Andres, M., Ramos, J. M., Arenas-Jiménez, J., ... & COVID19-ALC research group. (2021). Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. Journal of Infection, 82(3), 378-383.
Oronsky, B., Larson, C., Hammond, T. C., Oronsky, A., Kesari, S., Lybeck, M., & Reid, T. R. (2023). A review of persistent post-COVID syndrome (PPCS). Clinical reviews in allergy & immunology, 64(1), 66-74.
Peluso, M. J., Deveau, T. M., Munter, S. E., Ryder, D., Buck, A., Beck-Engeser, G., ... & Henrich, T. J. (2023). Chronic viral coinfections differentially affect the likelihood of developing long COVID. The Journal of Clinical Investigation, 133(3).
Salmanton-García, J., Busca, A., Cornely, O. A., Corradini, P., Hoenigl, M., Klimko, N., ... & Pagano, L. (2021). EPICOVIDEHA: a ready to use platform for epidemiological studies in hematological patients with COVID-19. Hemasphere, 5(7).
Schett, G., Sticherling, M., & Neurath, M. F. (2020). COVID-19: risk for cytokine targeting in chronic inflammatory diseases?. Nature Reviews Immunology, 20(5), 271-272.
Siripanthong, B., Nazarian, S., Muser, D., Deo, R., Santangeli, P., Khanji, M. Y., ... & Chahal, C. A. A. (2020). Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart rhythm, 17(9), 1463-1471.
Tudoran, C., Tudoran, M., Pop, G. N., Giurgi-Oncu, C., Cut, T. G., Lazureanu, V. E., ... & Bende, F. (2021). Associations between the severity of the post-acute COVID-19 syndrome and echocardiographic abnormalities in previously healthy outpatients following infection with SARS-CoV-2. Biology, 10(6), 469.
Unudurthi, S. D., Luthra, P., Bose, R. J., McCarthy, J. R., & Kontaridis, M. I. (2020). Cardiac inflammation in COVID-19: Lessons from heart failure. Life sciences, 260, 118482.
